The early years of on-line HDF: How did it all start? How did we get here?

Contributions to Nephrology

Volumn 175, Issue , 2011, Pages 93-109

  Canaud, Bernard ^a,b  

^a Nephrology   (France)

^b LAPEYRONIE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIALYSIS FLUID;

ARTICLE; CHRONIC DISEASE; HEMODIAFILTRATION; HISTORY; HUMAN; KIDNEY DISEASE; METHODOLOGY; TREATMENT OUTCOME;

CHRONIC DISEASE; DIALYSIS SOLUTIONS; HEMODIAFILTRATION; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; KIDNEY DISEASES; TREATMENT OUTCOME;

EID: 84855817407     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000333627     Document Type: Article

References (88)

1. Babb AL, Ahmad S, Bergström J, Scribner BH: The middle molecule hypothesis in perspective. Am J Kidney Dis 1981;1:46-50. (Pubitemid 12230314)
2. Gotch FA, Sargent JA: A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985;28:526.
3. Daugirdas JT, Depner TA: A nomogram approach to hemodialysis urea modeling. Am J Kidney Dis 1994;23:33.
4. K/DOQI Clinical Practice Guidelines and Clinical Practice Recommendations 2006 Updates Hemodialysis adequacy Peritoneal Dialysis Adequacy Vascular Access. Am J Kidney Dis 2006;48(suppl 1):S1.
5. Vanholder R, Baurmeister U, Brunet P, Cohen G, Glorieux G, Jankowski J, European Uremic Toxin Work Group: A bench to bedside view of uremic toxins. J Am Soc Nephrol 2008;19:863-870.
6. Kessler M, Canaud B, Pedrini L, Tattersall J, Marten Ter Wee P, Vanholder R, Wanner C: Section III. Biocompatibility. EBPG Expert Group on Haemodialysis. Nephrol Dial Transplant 2002;17(suppl 7):32-44.
7. Tolchin N, Roberts JL, Hayashi J, Lewis EJ: Metabolic consequences of high mass-transfer hemodialysis. Kidney Int 1977;11:366-378. (Pubitemid 8119710)
8. Leunissen KM, Kooman JP, van Kuijk W, van der Sande F, Luik AJ, van Hooff JP: Preventing haemodynamic instability in patients at risk for intra-dialytic hypotension. Nephrol Dial Transplant 1996;11(suppl 2):11-15. (Pubitemid 26182536)
9. Selby NM, McIntyre CW: The acute cardiac effects of dialysis. Semin Dial 2007;20:220-228.
10. Kjellstrand CM, Evans RL, Petersen RJ, Shideman JR, von Hartitzsch B, Buselmeier TJ: The 'unphysiology' of dialysis: A major cause of dialysis side effects? Kidney Int Suppl 1975;2:30-34.
11. Cibulka R, Racek J: Metabolic disorders in patients with chronic kidney failure. Physiol Res 2007;56:697-705.
12. Chapman GV, Ward RA, Farrell PC: Separation and quantification of the 'middle molecules' in uremia. Kidney Int 1980;17:82-88. (Pubitemid 10063515)
13. Vanholder R, Glorieux G, De Smet R, Lameire N, European Uremic Toxin Work Group: New insights in uremic toxins. Kidney Int Suppl 2003;84:S6-S10. (Pubitemid 36513363)
14. Thomas M, Moriyama K, Ledebo I: AN69: Evolution of the World's First High Permeability Membrane. Contrib Nephrol. Basel, Karger, 2011, vol 173, pp 119-129.
15. Bowry SK, Gatti E, Vienken J: Contribution of polysulfone membranes to the success of convective dialysis therapies. Contrib Nephrol. Basel, Karger, 2011, vol 173, pp 110-118.
16. Ronco C, Bowry SK, Brendolan A, Crepaldi C, Soffiati G, Fortunato A, Bordoni V, Granziero A, Torsello G, La Greca G: Hemodialyzer: From macro-design to membrane nanostructure; the case of the FX-class of hemodialyzers. Kidney Int Suppl 2002;80:126-142.
17. Graefe U, Milutinovich J, Follette WC, Vizzo JE, Babb AL, Scribner BH: Less dialysisinduced morbidity and vascular instability with bicarbonate in dialysate. Ann Intern Med 1978;88:332-336. (Pubitemid 8287465)
18. Zelman A, White M, Acker K, Neal T, Parsons R, Gisser D: A simple method for incorporating single pass dialysate delivery and controlled ultrafiltration with the RP-6 high-flux dialyzer. J Dial 1979;3:219-235. (Pubitemid 10217060)
19. Tetta C, Roy T, Gatti E, Cerutti S: The rise of hemodialysis machines: New technologies in minimizing cardiovascular complications. Expert Rev Cardiovasc Ther 2011;9:155-164.
20. Gordon SM, Oettinger CW, Bland LA, Oliver JC, Arduino MJ, Aguero SM, McAllister SK, Favero MS, Jarvis WR: Pyrogenic reactions in patients receiving conventional, highefficiency, or high-flux hemodialysis treatments with bicarbonate dialysate containing high concentrations of bacteria and endotoxin. J Am Soc Nephrol 1992;2:1436-1444.
21. Pegues DA, Oettinger CW, Bland LA, Oliver JC, Arduino MJ, Aguero SM, McAllister SK, Gordon SM, Favero MS, Jarvis WR: A prospective study of pyrogenic reactions in hemodialysis patients using bicarbonate dialysis fluids filtered to remove bacteria and endotoxin. J Am Soc Nephrol 1992;3:1002-1007.
22. Lonnemann G, Koch KM: Beta-2-microglobulin amyloidosis: Effects of ultrapure dialysate and type of dialyzer membrane. J Am Soc Nephrol 2002;13(suppl 1):S72-S77. (Pubitemid 34008181)
23. Lonnemann G: Should ultra-pure dialysate be mandatory? Nephrol Dial Transplant 2000;15(suppl 1):55-59. (Pubitemid 30114211)
24. Canaud B, Granger-Vallée A: Should ultrapure dialysate be part of standard therapy in hemodialysis? Semin Dial 2011;24:426-427.
25. Maduell F, Navarro V, Cruz MC, Torregrosa E, Garcia D, Simon V, Ferrero JA: Osteocalcin and myoglobin removal in on-line hemodiafiltration versus low-and high-flux hemodialysis. Am J Kidney Dis 2002;40:582-589. (Pubitemid 34971288)
26. Martín-Malo A, Aljama P: On-line hemodiafiltration reduces the proinflammatory CD14+CD16+ monocyte-derived dendritic cells: A prospective, crossover study. J Am Soc Nephrol 2006;17:2315-2321. (Pubitemid 44141923)
27. Henderson LW, Beans E: Successful production of sterile pyrogen-free electrolyte solution by ultrafiltration. Kidney Int 1978;14:522-525. (Pubitemid 9068294)
28. Henderson LW, Sanfelippo ML, Beans E: 'On line' preparation of sterile pyrogen-free electrolyte solution. Trans Am Soc Artif Intern Organs 1978;24:465-467. (Pubitemid 9066151)
29. Henderson LW: Hemofiltration and the middle molecule. Blood Purif 1999;17:175-177. (Pubitemid 29423678)
30. Quellhorst E: Long-term follow-up in chronic hemofiltration. Int J Artif Organs 1983;6:115-120.
31. Baldamus CA, Quellhorst E: Outcome of long-term hemofiltration. Kidney Int Suppl 1985;17:S41-S46.
32. Ramperez P, Beau MC, Deschodt G, Flavier JL, Nilsson L, Mion C, Shaldon S: Economic preparation of sterile pyrogen-free infusate for haemofiltration. Proc Eur Dial Transplant Assoc 1981;18:293-296.
33. Shaldon S, Beau MC, Deschodt G, Flavier JL, Nilsson L, Ramperez P, Mion C: Three years of experience with on-line preparation of sterile pyrogen-free infusate for haemofiltration. Contrib Nephrol. Basel, Karger, 1982, vol 32, pp 161-164.
34. Shaldon S, Beau MC, Deschodt G, Flavier JL, Nilsson L, Ramperez P, Mion C: Three years of experience with on-line preparation of sterile pyrogen-free infusate for hemofiltration. Int J Artif Organs 1983;6:25-26. (Pubitemid 13086225)
35. Canaud B, Flavier JL, Argilés A, Stec F, N'Guyen QV, Bouloux C, Garred LJ, Mion C: Hemodiafiltration with on-line production of substitution fluid: Long-term safety and quantitative assessment of efficacy. Contrib Nephrol. Basel, Karger, 1994, vol 108, pp 12-22.
36. Canaud B, Imbert E, Kaaki M, Assounga A, N'Guyen QV, Stec F, Garred LJ, Boström M, Mion C: Clinical and microbiological evaluation of a postdilutional hemofiltration system with in-line production of substitution fluid. Blood Purif 1990;8:160-170. (Pubitemid 20290568)
37. Canaud B, Araujo A, Sany C, Farrell PC, Garred LJ, Shaldon S, Mion C: A urea kinetic model for haemofiltration. Life Support Syst 1985;3:15-25. (Pubitemid 15112350)
38. Leber HW, Wizemann V, Goubeaud G, Rawer P, Schutterle G: Hemodiafiltration: A new alternative to hemofiltration and conventional hemodialysis. Artif Organs 1978;2:150-153. (Pubitemid 10187954)
39. Canaud B, N'Guyen QV, Lagarde C, Stec F, Polaschegg HD, Mion C: Clinical evaluation of a multipurpose dialysis system adequate for hemodialysis or for postdilution hemofiltration/ hemodiafiltration with on-line preparation of substitution fluid from dialysate. Contrib Nephrol. Basel, Karger, 1985, vol 46, pp 184-186.
40. Canaud BJ: Changing paradigms of renal replacement therapy in chronic kidney disease patients: Ultrapure dialysis fluid and high-efficiency hemodiafiltration for all? Kidney Int 2009;76:591-593.
41. Polaschegg HD, Roy T: Technical aspects of online hemodiafiltration. Contrib Nephrol. Basel, Karger, 2007, vol 158, pp 68-79.
42. Canaud B, Bosc JY, Leray-Moragues H, Stec F, Argiles A, Leblanc M, Mion C: On-line haemodiafiltration. Safety and efficacy in long-term clinical practice. Nephrol Dial Transplant 2000;15(suppl 1):60-67. (Pubitemid 30114212)
43. Canaud B, N'Guyen QV, Polito C, Stec F, Mion C: Hemodiafiltration with on-line production of bicarbonate infusate. A new standard for high-efficiency, low-cost dialysis in elderly and uncompliant patients. Contrib Nephrol. Basel, Karger, 1989, vol 74, pp 91-100.
44. Canaud B: Online hemodiafiltration. Technical options and best clinical practices. Contrib Nephrol. Basel, Karger, 2007, vol 158, pp 110-122.
45. Roy T: Technical and microbiological safety of online hemodiafiltration: A European perspective. Semin Dialysis 1999;12:S81-S87.
46. Canaud B, Mion C: Water treatment for contemporary hemodialysis; in Jacobs C, Kjellstrand CM, Koch KM, Winchester JF (eds): Replacement of Renal Function by Dialysis, ed 4. Dordrecht, Kluwer Academic, 1996, vol 8, pp 232-255.
47. Canaud B, Bosc JY, Leblanc M, Garred LJ, Vo T, Mion C: Evaluation of high-flux hemodiafiltration efficiency using an on-line urea monitor. Am J Kidney Dis 1998;31:74-80. (Pubitemid 28116686)
48. 2-microglobulin removal: Hemodialysis, hemofiltration, and push/pull HDF. Artif Organs 1989;13:66-70. (Pubitemid 19055201)
49. Vanholder R, Meert N, Schepers E, Glorieux G: From uremic toxin retention to removal by convection: Do we know enough? Contrib Nephrol. Basel, Karger, 2008, vol 161, pp 125-131.
50. Santoro A, Ferramosca E, Mancini E, Monari C, Varasani M, Sereni L, Wratten M: Reverse mid-dilution: New way to remove small and middle molecules as well as phosphate with high intrafilter convective clearance. Nephrol Dial Transplant 2007;22:2000-2005. (Pubitemid 47244773)
51. Lornoy W, De Meester J, Becaus I, Billiouw JM, Van Malderen PA, Van Pottelberge M: Impact of convective flow on phosphorus removal in maintenance hemodialysis patients. J Ren Nutr 2006;16:47-53. (Pubitemid 43088755)
52. Zehnder C, Gutzwiller JP, Renggli K: Hemodiafiltration: A new treatment option for hyperphosphatemia in hemodialysis patients. Clin Nephrol 52:152, 1999.
53. Penne EL, van der Weerd NC, van den Dorpel MA, Grooteman MP, Lévesque R, Nubé MJ, Bots ML, Blankestijn PJ, ter Wee PM, CONTRAST Investigators: Shortterm effects of online hemodiafiltration on phosphate control: A result from the randomized controlled Convective Transport Study (CONTRAST). Am J Kidney Dis 2010;55:77-87.
54. Davenport A, Gardner C, Delaney M, on behalf of the Pan Thames Renal Audit Group: The effect of dialysis modality on phosphate control: Haemodialysis compared to haemodiafiltration. The Pan Thames Renal Audit. Nephrol Dial Transplant 2010;25:897-901.
55. 2-microglobulin. Long-term clinical observations. Nephrol Dial Transplant 2000;15(suppl 1):49.
56. Maduell F, del Pozo C, Garcia H, et al: Change from conventional haemodiafiltration to on-line haemodiafiltration. Nephrol Dial Transplant 1999;14:1202.
57. 2-microglobulin during predilutional and postdilutional hemofiltration. Kidney Int 2005;68:2331-2337. (Pubitemid 43117812)
58. Locatelli F, Mastrangelo F, Redaelli B, et al: Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group. Kidney Int 1996;50:1293.
59. Susantitaphong P, Tiranathanagul K, Katavetin P, Townamchai N, Praditpornsilpa K, Tungsanga K, Eiam-Ong S: Efficacy of convective-controlled double high-flux hemodiafiltration versus on-line hemodiafiltration: One-year prospective study. Blood Purif 2010;29:35-43.
60. 2- microglobulin kinetics with three different dialysis modalities. Int J Artif Organs 2006;29:949-955. (Pubitemid 46017371)
61. Widjaja A, Kielstein JT, Horn R, et al: Free serum leptin but not bound leptin concentrations are elevated in patients with end-stage renal disease. Nephrol Dial Transplant 2000;15:846.
62. Kim S, Oh KH, Chin HJ, Na KY, Kim YS, Chae DW, Ahn C, Han JS, Kim S, Joo KW: Effective removal of leptin via hemodiafiltration with on-line endogenous reinfusion therapy. Clin Nephrol 2009;72:442-448.
63. Tetta C, Bellomo R, D'Intini V, et al: Do circulating cytokines really matter in sepsis? Kidney Int Suppl 2003;84:S69.
64. Van Tellingen A, Grooteman MP, Schoorl M, et al: Intercurrent clinical events are predictive of plasma C-reactive protein levels in hemodialysis patients. Kidney Int 2001;62:632.
65. Canaud B, Wizemann V, Pizzarelli F, et al: Cellular interleukin-1 receptor antagonist production in patients receiving on-line haemodiafiltration therapy. Nephrol Dial Transplant 2001;16:2181.
66. Carracedo J, Merino A, Nogueras S, Carretero D, Berdud I, Ramírez R, Tetta C, Rodríguez M, Martín-Malo A, Aljama P: Online hemodiafiltration reduces the proinflammatory CD14+CD16+ monocyte-derived dendritic cells: A prospective, crossover study. J Am Soc Nephrol 2006;17:2315-2321. (Pubitemid 44141923)
67. Stein G, Franke S, Mahiout A, et al: Influence of dialysis modalities on serum AGE levels in end-stage renal disease patients. Nephrol Dial Transplant 2001;16:999.
68. Niwa T, Asada H, Tsutsui S, et al: Efficient removal of albumin-bound furancarboxylic acid by protein-leaking hemodialysis. Am J Nephrol 1995;15:463.
69. Kawano Y, Takaue Y, Kuroda Y, et al: Effect of alleviation of renal anemia by hemodialysis using the high-flux dialyzer BK-F. Kidney Dial 1994;200.
70. Meijers BK, Van Kerckhoven S, Verbeke K, Dehaen W, Vanrenterghem Y, Hoylaerts MF, Evenepoel P: The uremic retention solute p-cresyl sulfate and markers of endothelial damage. Am J Kidney Dis 2009;54:891-901.
71. Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y: Removal of the proteinbound solute p-cresol by convective transport: A randomized crossover study. Am J Kidney Dis 2004;44:278-285. (Pubitemid 38962556)
72. Krieter DH, Hackl A, Rodriguez A, Chenine L, Moragues HL, Lemke HD, Wanner C, Canaud B: Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration. Nephrol Dial Transplant 2010;25:212-218.
73. Altieri P, Sorba G, Bolasco P, Asproni E, Ledebo I, Cossu M, Ferrara R, Ganadu M, Cadinu F, Serra G, Cabiddu G, Sau G, Casu D, Passaghe M, Bolasco F, Pistis R, Ghisu T, Second Sardinian Multicentre Study: Predilution haemofiltration -the Second Sardinian Multicentre Study: Comparisons between haemofiltration and haemodialysis during identical Kt/V and session times in a long-term cross-over study. Nephrol Dial Transplant 2001;16:1207-1213. (Pubitemid 32547377)
74. Mion M, Kerr PG, Argiles A, Canaud B, Flavier JL, Mion C: Haemodiafiltration in high-cardiovascular-risk patients. Nephrol Dial Transplant 1992;7:453-454.
75. Tiranathanagul K, Praditpornsilpa K, Katavetin P, Srisawat N, Townamchai N, Susantitaphong P, Tungsanga K, Eiam-Ong S: On-line hemodiafiltration in Southeast Asia: A three-year prospective study of a single center. Ther Apher Dial 2009;13:56-62.
76. McKane W, Chandna SM, Tattersall JE, et al: Identical decline of residual renal function in high-flux biocompatible hemodialysis and CAPD. Kidney Int 2002;61:256.
77. Locatelli F, Del Vecchio L: Dialysis adequacy and response to erythropoietic agents: What is the evidence base? Nephrol Dial Transplant 2003;18(suppl 8):viii, 29-35.
78. Vaslaki L, Major L, Berta K, Karatson A, Misz M, Pethoe F, Ladanyi E, Fodor B, Stein G, Pischetsrieder M, Zima T, Wojke R, Gauly A, Passlick-Deetjen J: On-line haemodiafiltration versus haemodialysis: Stable haematocrit with less erythropoietin and improvement of other relevant blood parameters. Blood Purif 2006;24:163-173. (Pubitemid 43259169)
79. Muñoz R, Gallardo I, Valladares E, Saracho R, Martínez I, Ocharan J, Montenegro J: Online hemodiafiltration: Four years of clinical experience. Hemodial Int 2006;10(suppl 1):S28-S32. (Pubitemid 43263305)
80. Fischbach M, Dheu C, Seuge L, Orfanos N: Hemodialysis and nutritional status in children: Malnutrition and cachexia. J Ren Nutr 2009;19:91-94.
81. Schwalbe S, Holzhauer M, Schaeffer J, Galanski M, Koch KM, Floege J: Beta-2-microglobulin-associated amyloidosis: A vanishing complication of long-term hemodialysis? Kidney Int 1997;52:1077-1083. (Pubitemid 27435842)
82. Fischbach M, Terzic J, Menouer S, Dheu C, Seuge L, Zalosczic A: Daily on-line haemodiafiltration promotes catch-up growth in children on chronic dialysis. Nephrol Dial Transplant 2010;25:867-873.
83. Canaud B, Bragg-Gresham JL, Marshall MR, Desmeules S, Gillepsie BW? Depner T, Klassen P, Port F: Patients receiving hemodiafiltration or hemofiltration have lower mortality risk than patients receiving hemodialysis without replacement fluid in Europe: The Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 2004;14:31A.
84. Jirka T, Cesare S, Di Benedetto A, Perera Chang M, Ponce P, Richards N, Tetta C, Vaslaky L: Mortality risk for patients receiving hemodiafiltration versus hemodialysis. Kidney Int 2006;70:1524. (Pubitemid 44527327)
85. Vilar E, Fry AC, Wellsted D, Tattersall JE, Greenwood RN, Farrington K: Long-term outcomes in online hemodiafiltration and high-flux hemodialysis: A comparative analysis. Clin J Am Soc Nephrol 2009;4:1944-1953.
86. Ercan O, Gulay A, Ebru S, et al: Comparison of postdilution on-line hemodiafiltration and hemodialysis. ERA-EDTA 2011, LBCT2.
87. Grooteman M, van den Dorpel R, Bots M, Penne L, van der Weerd N, Mazairac A, Den Hoedt C, Van der Tweel I, Lévesque R, Nubé M, Ter Wee P, Blankestijn P: Online hemodiafiltration versus low-flux hemodialysis: Effects on all-cause mortality and cardiovascular events in a randomized controlled trial. The convective transport study (CONTRAST). ERA-EDTA 2011, LBCT1.
88. Blankestijn PJ, Ledebo I, Canaud B: Hemodiafiltration: Clinical evidence and remaining questions. Kidney Int. 2010;77:581-587.